Stephen M. Picea, MD
This content is PDF only. Please click on the PDF icon to access.
To the editor: In their otherwise enlightening editorial, Armstrong and Bernard (1) are extremely ambiguous in their conclusion concerning the appropriateness of using aerosolized pentamidine for therapy (not prophylaxis) for pneumocystis infection.
At one point, they state "aerosol therapy by itself is contraindicated," whereas in the last paragraph they conclude, "aerosol pentamidine should not be used for treatment ..." It is not clear if the authors feel it is appropriate to use aerosolized pentamidine as adjunctive therapy, pending further studies. A clarification would be appreciated.
Picea SM. Aerosolized Pentamidine. Ann Intern Med. ;110:574. doi: 10.7326/0003-4819-110-7-574_1
Download citation file:
Published: Ann Intern Med. 1989;110(7):574.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use